Contemporary Management of HIV: New Data From AIDS 2018

In these live, interactive workshops, expert faculty will review key findings from the International AIDS Conference and discuss how they affect optimal management of patients with HIV.

Agenda

  • Introduction and Program Overview
  • Key Findings From AIDS 2018
    • Updates on HIV Prevention
    • New Strategies in ART Management
    • First-line and Switch ART Strategies
    • Managing ART in Patients With Common Comorbidities
  • Question and Answer Session

Events

Date / Time
Event Details
8/22/2018
6:00 PM
8/23/2018
6:00 PM
8/28/2018
6:00 PM

Contemporary Management of HIV: New Data From AIDS 2018

Washington, DC
Del Frisco's Steakhouse-Washington, DC Details
9/12/2018
6:00 PM

Faculty

Program Director
Joseph J. Eron, MD

Professor of Medicine and Epidemiology
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina

Program Director
Princy N. Kumar, MD

Professor of Medicine and Microbiology
Division of Infectious Diseases
Georgetown University Hospital
Division Chief
Division of Infectious Diseases and Travel Medicine
Department of Internal Medicine
Medstar Georgetown University Hospital
Washington, DC

Faculty
Roger Bedimo, MD, MS, FACP

Professor of Medicine
Division of Infectious Diseases
University of Texas Southwestern Medical Center
Section Chief
Division of Infectious Diseases
Department of Internal Medicine
VA North Texas Health Care System
Dallas, Texas

Faculty
Eric S. Daar, MD

Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

Faculty
Ian Frank, MD

Professor of Medicine
University of Pennsylvania
Director, Clinical Therapeutics Program
Penn Center for AIDS Research
Philadelphia, Pennsylvania

Faculty
Monica Gandhi, MD, MPH

Professor of Medicine
Division of HIV, Infectious Diseases, and Global Medicine
University of California, San Francisco
Medical Director
Ward 86 HIV Clinic
San Francisco General Hospital
San Francisco, California

Faculty
W. David Hardy, MD

Adjunct Professor of Medicine
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, Maryland
Senior Director of Evidence-Based Practices
Whitman-Walker Health
Washington, DC

Faculty
Lisa Hightow-Weidman, MD

Associate Professor
Division of Infectious Diseases
Department of Medicine
University of North Carolina, Chapel Hill
Chapel Hill, North Carolina

Faculty
Daniel Kuritzkes, MD

Chief, Division of Infectious Diseases
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Faculty
David A. Wohl, MD

Professor of Medicine
School of Medicine
Site Leader, AIDS Clinical Trials Unit-Chapel Hill
University of North Carolina at Chapel Hill
Director, North Carolina AIDS Training and Education Center
Chapel Hill, North Carolina
Co-Director, HIV Services
North Carolina Department of Correction
Raleigh, North Carolina

CME

Program Overview
New in 2018! In this engaging live postconference workshop series available throughout the United States, expert faculty review data presented at AIDS 2018 and how key findings integrate into existing best practices, highlighting the most important resultant changes to their own patient management.

Goal
The goal of this activity is to improve participants’ competence in providing optimal care for HIV-infected patients.

Target Audience
This program is intended for physicians, registered nurses, pharmacists, and other healthcare professionals who provide care for HIV-infected patients.

Learning Objectives

  • Incorporate the results of recent clinical studies that appropriately reflect the latest findings when utilizing antiretroviral agents for treatment-naive or treatment-experienced patients with HIV infection
  • Provide insightful counsel to patients and colleagues regarding studies of investigational antiretroviral agents and strategies in advanced stages of development
  • Evaluate the impact of clinical studies of strategies for HIV prevention

Accreditation

Physician Continuing Medical Education

Accreditation Designation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Albert Einstein College of Medicine and Clinical Care Options. The Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
Albert Einstein College of Medicine designates this live meeting for a maximum of 2.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Credit Designation
Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Credit Designation
2.5 contact hours may be earned for successful completion of this activity.

California Board of Registered Nursing
Provider approved by the California Board of Registered Nursing, Provider Number 13664, for 2.5 contact hours.

A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be emailed to you within 4 weeks.

Pharmacist Continuing Education

Accreditation Statement
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation
This program has been assigned ACPE Universal Activity #0797-9999-18-085-L02-P. This program is designated for up to 2.5 contact hours (0.25 CEUs) of continuing pharmacy education credit. 

Type of Activity:
 Application

For Pharmacists: Upon receipt of the completed activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.

Disclosure of Conflicts of Interest
The "Conflict of Interest Disclosure Policy" of Albert Einstein College of Medicine requires that faculty participating in any CME activity disclose to the audience any relationship with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest with regard to their contribution to the activity will not be permitted to present.

The Albert Einstein College of Medicine also requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

The staff of the Center for Continuing Medical Education of Albert Einstein College of Medicine have no conflict of interest with commercial interests related directly or indirectly to this educational activity.

The Annenberg Center for Health Sciences at Eisenhower requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to the Annenberg Center for Health Sciences at Eisenhower policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.

Peer Reviewer: Barry S. Zingman, MD, Medical Director, AIDS Center; Clinical Director, Infectious Diseases, Moses Division; and Professor of Clinical Medicine at Albert Einstein College of Medicine has no real or apparent conflicts of interest to report.